Improving Cell Recycling System to Treat Lysosomal Storage Disease

News   Jul 18, 2017 | Original Story from the NIH NCATS

 
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

The compound methyl-β-cyclodextrin turns on an enzyme, AMPK, triggering a response against a rare genetic disease, NPC1. Credit: NCATS

 
 
 

RELATED ARTICLES

Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass Spec

News

Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.

READ MORE

Absence Epilepsy Seizures Visualized in the Brain

News

Researchers took a closer look at the firing activity of neurons in an area of the visual cortex of a genetic mouse model of absence epilepsy.

READ MORE

Psychedelics and the Potential of Plant Medicine

News

Hallucinogenic drugs are having a moment. A series of recent studies suggests that psychedelics may be useful for alleviating depression and anxiety, PTSD, and addiction.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy